- Thermo Fisher Scientific (NYSE:TMO) Q4 results ($M): Total Revenues: 4,492.8 (+29.6%); Life Sciences Solutions: 1,185.2 (+518.3); Analytical Instruments: 902.4 (+1.7%); Specialty Diagnostics: 863.0 (+3.6%); Lab Products & Services: 1,682,9 (+1.8%).
- COGS: 2,290.8 (+18.6%); R&D Expense: 182.5 (+74.3%); SG&A Expense: 1,007.4 (+31.9%); Net Income: 601.2 (+75.7%); EPS: 1.49 (+62.0%); CF Ops: 953.7 (+30.9%); Quick Assets: 1,352.0 (-76.8%).
- Gross Profit: 2,202.0 (+43.4%); COGS: 51.0% (-8.5%); Gross Margin: 49.0% (+10.6%); Operating Earnings: 1,012.1 (+51.7%); Operating Earnings Yield: 22.5% (+17.1%); Net Earnings Yield: 13.4% (+35.6%).
- 2015 Guidance will be provided during the conference call this morning.